Corcept Therapeutics (CORT) Insider Trading & Ownership $56.09 +1.79 (+3.30%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Corcept Therapeutics (NASDAQ:CORT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)13Amount OfInsider Selling(Last 12 Months)$7.99 M Get CORT Insider Trade Alerts Want to know when executives and insiders are buying or selling Corcept Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CORT Insider Buying and Selling by Quarter Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Corcept Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/11/2024Daniel N. Swisher, Jr.DirectorSell2,200$59.88$131,736.00 11/4/2024William GuyerInsiderSell3,394$48.97$166,204.18 11/1/2024William GuyerInsiderSell6,606$48.97$323,495.82 10/1/2024Gary Charles RobbInsiderSell11,000$46.28$509,080.00 9/3/2024William GuyerInsiderSell10,000$35.30$353,000.00 8/26/2024Gary Charles RobbInsiderSell3,101$35.71$110,736.71 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/1/2024Daniel N. Swisher, Jr.DirectorSell150$38.50$5,775.00 8/1/2024William GuyerInsiderSell10,000$38.67$386,700.00 7/1/2024Daniel N. Swisher, Jr.DirectorSell2,200$32.81$72,182.00 7/1/2024Joseph Douglas LyonInsiderSell5,000$32.49$162,450.00 6/3/2024Daniel N. Swisher, Jr.DirectorSell2,200$30.21$66,462.00 6/3/2024Joseph Douglas LyonInsiderSell5,000$30.18$150,900.00 5/28/2024Gary Charles RobbInsiderSell11,000$30.39$334,290.00 5/13/2024Sean MaduckInsiderSell50,000$28.00$1,400,000.00 5/9/2024Joseph Douglas LyonInsiderSell7,227$26.00$187,902.00 5/2/2024Joseph Douglas LyonInsiderSell10,830$26.00$281,580.00 4/4/2024Joseph Douglas LyonInsiderSell5,443$26.00$141,518.00 4/1/2024Daniel N. Swisher, Jr.DirectorSell2,200$25.30$55,660.00 4/1/2024Joseph Douglas LyonInsiderSell500$26.01$13,005.00 3/27/2024Sean MaduckInsiderSell25,953$25.01$649,084.53 3/18/2024Sean MaduckInsiderSell17,219$25.00$430,475.00 3/1/2024Daniel N. Swisher, Jr.DirectorSell2,200$23.59$51,898.00 2/16/2024Joseph Douglas LyonCAOSell1,000$26.00$26,000.00 2/16/2024Sean MaduckInsiderSell27,068$25.97$702,955.96 2/1/2024Daniel N. Swisher, Jr.DirectorSell2,200$22.00$48,400.00 1/2/2024Daniel N. Swisher, Jr.DirectorSell2,200$22.11$48,642.00 12/22/2023William GuyerInsiderSell10,000$32.00$320,000.00 12/5/2023Gary Charles RobbInsiderSell1,381$26.27$36,278.87 12/4/2023Joseph Douglas LyonCAOSell2,432$26.00$63,232.00 12/1/2023Daniel N. Swisher, Jr.DirectorSell2,200$25.47$56,034.00 12/1/2023Joseph Douglas LyonCAOSell2,568$26.00$66,768.00 12/1/2023Sean MaduckInsiderSell25,000$25.56$639,000.00 (Data available from 1/1/2013 forward) CORT Insider Trading Activity - Frequently Asked Questions Who is on Corcept Therapeutics's Insider Roster? The list of insiders at Corcept Therapeutics includes Daniel N. Swisher, Jr., David L Mahoney, Gary Charles Robb, Hazel Hunt, Joseph Douglas Lyon, Joseph K Belanoff, Sean Maduck, and William Guyer. Learn more on insiders at CORT. What percentage of Corcept Therapeutics stock is owned by insiders? 20.50% of Corcept Therapeutics stock is owned by insiders. Learn more on CORT's insider holdings. Which Corcept Therapeutics insiders have been selling company stock? The following insiders have sold CORT shares in the last 24 months: Daniel N. Swisher, Jr. ($867,415.50), David L Mahoney ($773,750.00), Gary Charles Robb ($1,831,794.00), Hazel Hunt ($631,854.95), Joseph Douglas Lyon ($1,896,985.01), Sean Maduck ($5,474,784.00), and William Guyer ($1,549,400.00). How much insider selling is happening at Corcept Therapeutics? Insiders have sold a total of 445,455 Corcept Therapeutics shares in the last 24 months for a total of $13,025,983.46 sold. Corcept Therapeutics Key ExecutivesDr. Joseph K. Belanoff M.D. (Age 67)Co-Founder, President, CEO & Director Compensation: $2.43MMr. Atabak Mokari (Age 47)CFO & Treasurer Compensation: $863.03kMr. Sean Maduck (Age 47)President of Endocrinology Compensation: $1.05MDr. William Guyer Pharm.D. (Age 56)Chief Development Officer Compensation: $1.03MMr. Gary Charles Robb (Age 61)Chief Business Officer & Secretary Compensation: $1.08M3 recent tradesMr. Joseph Douglas Lyon (Age 46)Chief Accounting & Technology Officer 2 recent tradesDr. Hazel Hunt Ph.D. (Age 64)Chief Scientific Officer Compensation: $895.16kMs. Amy FloodChief Human Resources & Communications OfficerMs. Monica Tellado (Age 51)President of Emerging Markets Mr. Roberto W. VieiraPresident of Oncology More Insider Trading Tools from MarketBeat Related Companies AXSM Insider Ownership HRMY Insider Ownership XNCR Insider Ownership OPK Insider Ownership AVIR Insider Ownership ADCT Insider Ownership RPRX Insider Ownership JAZZ Insider Ownership PRGO Insider Ownership SUPN Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:CORT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CORT Stock Alerts